Cogentix Medical (CGNT) and Alere (ALR) Financial Survey

Cogentix Medical (NASDAQ: CGNT) and Alere (NYSE:ALR) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, risk, profitability, dividends and earnings.

Profitability

This table compares Cogentix Medical and Alere’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Cogentix Medical -36.14% -11.55% -10.12%
Alere -16.86% -33.39% -6.72%

Risk and Volatility

Cogentix Medical has a beta of 0.69, suggesting that its share price is 31% less volatile than the S&P 500. Comparatively, Alere has a beta of 0.21, suggesting that its share price is 79% less volatile than the S&P 500.

Insider and Institutional Ownership

12.5% of Cogentix Medical shares are held by institutional investors. Comparatively, 89.3% of Alere shares are held by institutional investors. 62.7% of Cogentix Medical shares are held by company insiders. Comparatively, 3.7% of Alere shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Cogentix Medical and Alere, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cogentix Medical 0 0 2 0 3.00
Alere 0 4 0 0 2.00

Cogentix Medical currently has a consensus target price of $4.50, suggesting a potential upside of 66.05%. Alere has a consensus target price of $51.00, suggesting a potential upside of 0.02%. Given Cogentix Medical’s stronger consensus rating and higher possible upside, analysts plainly believe Cogentix Medical is more favorable than Alere.

Earnings and Valuation

This table compares Cogentix Medical and Alere’s top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio NetIncome Earnings Per Share Price/Earnings Ratio
Cogentix Medical $51.85 million 3.18 -$22.09 million ($0.41) -6.61
Alere N/A N/A N/A ($3.11) -16.40

Alere has higher revenue, but lower earnings than Cogentix Medical. Alere is trading at a lower price-to-earnings ratio than Cogentix Medical, indicating that it is currently the more affordable of the two stocks.

Summary

Cogentix Medical beats Alere on 8 of the 11 factors compared between the two stocks.

About Cogentix Medical

Cogentix Medical, Inc. is a global medical device company. The Company designs, develops, manufactures and markets a line of fiber-optic and video endoscopy products under the PrimeSight brand that are used across various surgical specialties in diagnostic and treatment procedures. The Company also offers the Urgent PC Neuromodulation System (Urgent PC Systems), a device that delivers percutaneous tibial nerve stimulation (PTNS), for the office-based treatment of overactive bladder (OAB). The Company also offers Macroplastique Implants, an injectable urethral bulking agent for the treatment of adult female stress urinary incontinence that is primarily due to intrinsic sphincter deficiency. The PrimeSight flexible endoscopes are used in conjunction with the sterile, single-use microbial barrier known as the EndoSheath Protective Barrier. The PrimeSight endoscopy line also includes rigid endoscopes and portable peripherals, such as the video system and stroboscopy unit.

About Alere

Alere Inc. is a provider of health information through diagnostic tests. The Company’s segments include professional diagnostics, consumer diagnostics, and corporate and other. The professional diagnostics segment includes an array of diagnostic test products and other in vitro diagnostic tests marketed to medical professionals and laboratories for detection of diseases and conditions within its areas of focus. The consumer diagnostics segment consists primarily of manufacturing operations related to its role as the exclusive manufacturer of products for SPD Swiss Precision Diagnostics (SPD), its joint venture with The Procter & Gamble Company (P&G). The Company’s professional diagnostic solutions allow patients and their healthcare providers to work together to manage patients’ conditions over the continuum of care, from the hospital to home. The Company offers lines of drugs-of-abuse tests, reagent systems and laboratory testing options.

Receive News & Ratings for Cogentix Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cogentix Medical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply